0001209191-17-033224.txt : 20170517 0001209191-17-033224.hdr.sgml : 20170517 20170517170957 ACCESSION NUMBER: 0001209191-17-033224 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170515 FILED AS OF DATE: 20170517 DATE AS OF CHANGE: 20170517 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Myovant Sciences Ltd. CENTRAL INDEX KEY: 0001679082 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 20-22 BEDFORD ROW CITY: LONDON STATE: X0 ZIP: WC1R 4JS BUSINESS PHONE: (441) 824-8101 MAIL ADDRESS: STREET 1: 20-22 BEDFORD ROW CITY: LONDON STATE: X0 ZIP: WC1R 4JS REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KARBE FRANK CENTRAL INDEX KEY: 0001276700 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37929 FILM NUMBER: 17852526 MAIL ADDRESS: STREET 1: C/O ARBUTUS BIOPHARMA CORP. STREET 2: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-15 0 0001679082 Myovant Sciences Ltd. MYOV 0001276700 KARBE FRANK C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY BRISBANE CA 94005 0 1 0 0 Principal Fin'l & Accounting Stock Option (Right to Buy) 12.68 2017-05-15 4 A 0 200000 0.00 A 2027-05-14 Common Shares 200000 200000 D 25% of the shares underlying the option vest and become exercisable on May 15, 2018; the balance of the shares vest and become exercisable in a series of twelve (12) successive equal quarterly installments measured from May 15, 2018, subject to the Reporting Person providing continuous service to the Issuer on each such date. /s/Alison Haggerty, Attorney-in-Fact 2017-05-17